Skip to main content
. 2021 Jun 30;114:105131. doi: 10.1016/j.bioorg.2021.105131

Table 3.

Kinase inhibitory properties of the promising antiproliferative 3-alkenyl-2-oxindoles (6a–c, 10a–c) synthesized and Sunitinib.

Entry Compd. IC50 (nM ± SD)
VEGFR-2 c-kit
1 6a 54.03 ± 5.4 119.8 ± 12.0
2 6b 98.95 ± 9.9 247.7 ± 24.8
3 6c 36.86 ± 3.7 72.35 ± 7.2
4 10a 102.2 ± 10.2 103.3 ± 10.3
5 10b 74.06 ± 7.4 184.9 ± 18.5
6 10c 53.36 ± 5.3 81.7 ± 8.2
7 Sunitinib 47.54 ± 4.8 84.9 ± 8.5